Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	36.41	58.18	61.69	165.75	84.77	62.44
Short-Term Investments	241.03	508.68	388.56	387.13	276.82	336.09
Cash & Short-Term Investments	277.44	566.85	450.25	552.88	361.59	398.52
Cash Growth	-56.28%	25.90%	-18.56%	52.90%	-9.27%	-15.48%
Accounts Receivable	25.17	21.18	16.65	15.91	15.93	18.05
Other Receivables	2.5	4.6	1.9	0.9	17.14	1.4
Receivables	27.67	25.78	18.55	16.81	33.07	19.44
Inventory	6.36	9.41	4.52	7.31	7.61	6.08
Prepaid Expenses	13.28	14.74	10.13	5.82	8.14	5.02
Other Current Assets	-	-	2.99	-	-	-
Total Current Assets	324.74	616.78	486.44	582.83	410.41	429.06
Property, Plant & Equipment	21.82	25.54	30.05	34.3	35.09	2.89
Goodwill	0.75	0.75	0.75	0.94	0.94	0.94
Other Intangible Assets	103.46	103.69	96.32	147.5	153.19	157.2
Other Long-Term Assets	53.64	42.16	59.03	11.07	7.81	14.71
Total Assets	504.41	788.91	672.59	776.63	607.44	604.8
Accounts Payable	23.2	41.68	17.29	15.14	12.13	26.61
Accrued Expenses	83.56	107.57	95.74	75.18	56.79	51.75
Current Portion of Long-Term Debt	68.6	-	-	-	-	-
Current Portion of Leases	5.3	4.91	4.43	3.91	0.36	-
Current Unearned Revenue	3.8	7.1	11.98	16.27	-	-
Other Current Liabilities	5.59	16.66	12.72	13.59	23.38	17.09
Total Current Liabilities	190.04	177.91	142.16	124.09	92.66	95.45
Long-Term Debt	309.96	377.26	375.55	226.58	215.34	204.86
Long-Term Leases	18.58	22.61	27.51	31.5	28.34	-
Long-Term Unearned Revenue	-	1.84	10.93	20.38	-	-
Other Long-Term Liabilities	16.29	8.49	73.59	71.98	59.89	83.29
Total Liabilities	534.86	588.1	629.73	474.52	396.23	383.6
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,357	1,328	1,060	1,069	797.99	636.91
Retained Earnings	-1,387	-1,126	-1,014	-765.97	-585.88	-416.44
Comprehensive Income & Other	-1.02	-1.46	-2.91	-0.56	-0.9	0.73
Shareholders' Equity	-30.45	200.81	42.85	302.11	211.21	221.2
Total Liabilities & Equity	504.41	788.91	672.59	776.63	607.44	604.8
Total Debt	402.43	404.78	407.49	261.99	244.03	204.86
Net Cash (Debt)	-125	162.07	42.76	290.9	117.56	193.66
Net Cash Growth	-	279.04%	-85.30%	147.45%	-39.30%	-23.75%
Net Cash Per Share	-1.62	2.18	0.67	4.86	2.47	4.57
Filing Date Shares Outstanding	78.05	76.1	64.74	63.21	60.24	43.12
Total Common Shares Outstanding	77.91	75.37	64.29	62.49	52.25	43.09
Working Capital	134.7	438.87	344.27	458.74	317.75	333.62
Book Value Per Share	-0.39	2.66	0.67	4.83	4.04	5.13
Tangible Book Value	-134.66	96.37	-54.22	153.68	57.09	63.06
Tangible Book Value Per Share	-1.73	1.28	-0.84	2.46	1.09	1.46
Machinery	-	5.06	4.99	4.73	2.39	1.83
Construction In Progress	-	0.17	0.08	0.63	6.34	0.25
Leasehold Improvements	-	9.69	9.18	8.79	4.63	2.65

Source: S&P Capital IQ. Standard template. Financial Sources.